Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients:: Matched-pair comparison with conventional radiotherapy

被引:98
作者
Graff, Pierre
Lapeyre, Michel
Desandes, Emnianuel
Ortholan, Cecile
Bensadoun, Rene-Jean
Alfonsi, Marc
Maingon, Philippe
Giraud, Philippe
Bourhis, Jean
Marchesi, Vincent
Mege, Alice
Peiffert, Didier
机构
[1] Ctr Alexis Vautrin, Serv Radiotherapie, Dept Radiat Oncol, F-54511 Vandoeuvre Les Nancy, France
[2] Ctr Alexis Vautrin, Dept Clin Res, Vandoeuvre Les Nancy, France
[3] Jean Perrin Ctr, Dept Radiat Oncol, Clermont Ferrand, France
[4] Ctr Antoine Lacassagne, Dept Radiat Oncol, F-06054 Nice, France
[5] St Catherine Ctr, Dept Radiat Oncol, Avignon, France
[6] Georges Francois Leclerc Ctr, Dept Radiat Oncol, Dijon, France
[7] Inst Curie, Dept Radiat Oncol, Paris, France
[8] Inst Gustave Roussy, Dept Radiat Oncol, Paris, France
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 67卷 / 05期
关键词
intensity-modulated radiotherapy; quality of life; head and neck cancer; cross-sectional study; matched-pair analysis;
D O I
10.1016/j.ijrobp.2006.11.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To assess the benefit of intensity-modulated radiotherapy (IMRT) compared with conventional RT for the quality of life (QOL) of head and neck cancer survivors. Methods and Materials: Cross-sectional QOL measures (European Organization for Research and Treatment of Cancer QOL questionnaire C30 and head and neck cancer module) were used with a French multicenter cohort of patients cured of head and neck cancer (follow-up >= 1 year) who had received bilateral neck RT (>= 45 Gy) as a part of their initial treatment. We compared the QOL mean scores regarding RT modality (conventional RT vs. IMRT). The patients of the two groups were matched (one to one) according to the delay between the end of RT and the timing of the QOL evaluation and the T stage. Each QOL item was divided into two relevant levels of severity: "not severe" (responses, "not at all" and "a little") vs. "severe" (responses "quite a bit" and "very much"). The association between the type of RT and the prevalence of severe symptoms was approximated, through multivariate analysis using the prevalence odds ratio. Results: Two comparable groups (67 pairs) were available. Better scores were observed on the head and neck cancer module QOL questionnaire for the IMRT group, especially for dry mouth and sticky saliva (p < 0.0001). Severe symptoms were more frequent with conventional RT concerning saliva modifications and oral discomfort. The adjusted prevalence odds ratios were 3.17 (p = 0.04) for dry mouth, 3.16 (p = 0.02) for sticky saliva, 3.58 (p = 0.02) for pain in the mouth, 3.35 (p = 0.04) for pain in the jaw, 2.60 (p = 0.02) for difficulties opening the mouth, 2.76 (p = 0.02) for difficulties with swallowing, and 2.68 (p = 0.03) for trouble with eating. Conclusion: The QOL assessment of head and neck cancer survivors demonstrated the benefit of IMRT, particularly in the areas of salivary dysfunction and oral discomfort. (c) 2007 Elsevier Inc.
引用
收藏
页码:1309 / 1317
页数:9
相关论文
共 37 条
[1]  
Aaronson N. K., 2001, EORTC QLQ C30 SCORIN
[2]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[3]   Quality of life and head and neck cancer: A 5 year prospective study [J].
Abendstein, H ;
Nordgren, M ;
Boysen, M ;
Jannert, M ;
Silander, E ;
Ahlner-Elmqvist, M ;
Hammerlid, E ;
Bjordal, K .
LARYNGOSCOPE, 2005, 115 (12) :2183-2192
[4]   Correlates of health-related quality of life in upper aerodigestive tract cancer patients [J].
Allison, PJ ;
Locker, D ;
Wood-Dauphinee, S ;
Black, M ;
Feine, JS .
QUALITY OF LIFE RESEARCH, 1998, 7 (08) :713-722
[5]   Quality of life in head and neck cancer patients:: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire -: H&N35 [J].
Bjordal, K ;
Hammerlid, E ;
Ahlner-Elmqvist, M ;
de Graeff, A ;
Boysen, M ;
Evensen, JF ;
Biörklund, A ;
de Leeuw, JRJ ;
Fayers, PM ;
Jannert, M ;
Westin, T ;
Kaasa, S .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :1008-1019
[6]   A prospective study of quality of life in head and neck cancer patients.: Part II:: Longitudinal data [J].
Bjordal, K ;
Ahlner-Elmqvist, M ;
Hammerlid, E ;
Boysen, M ;
Evensen, JF ;
Biörklund, A ;
Jannert, M ;
Westin, T ;
Kaasa, S .
LARYNGOSCOPE, 2001, 111 (08) :1440-1452
[7]   A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients [J].
Bjordal, K ;
de Graeff, A ;
Fayers, PM ;
Hammerlid, E ;
van Pottelsberghe, C ;
Curran, D ;
Ahlner-Elmqvist, M ;
Maher, EJ ;
Meyza, JW ;
Brédart, A ;
Söderholm, AL ;
Arraras, JJ ;
Feine, JS ;
Abendstein, H ;
Morton, RP ;
Pignon, T ;
Huguenin, P ;
Bottomly, A ;
Kaasa, S .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (14) :1796-1807
[8]   A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer [J].
Bowker, Samantha L. ;
Pohar, Sheri L. ;
Johnson, Jeffrey A. .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
[9]   A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results [J].
Chao, KSC ;
Deasy, JO ;
Markman, J ;
Haynie, J ;
Perez, CA ;
Purdy, JA ;
Low, DA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (04) :907-916
[10]   Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx [J].
Clark, CH ;
Bidmead, AM ;
Mubata, CD ;
Harrington, KJ ;
Nutting, CM .
RADIOTHERAPY AND ONCOLOGY, 2004, 70 (02) :189-198